Encompass Health CMO reports tax-share withholding

Encompass Health Corp’s Chief Medical Officer, Elissa Joy Charbonneau, reported a tax-related share disposition.

Accepted by SEC EDGAR 02/25/2026 - 09:14 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Encompass Health Corp’s Chief Medical Officer, Elissa Joy Charbonneau, reported a tax-related share disposition. On this Form 4, 440 shares of Encompass Health common stock were withheld to cover tax obligations from vesting restricted stock, at a reference price of $106.15 per share. After this tax-withholding transaction, she held a total of 18,013.061 shares directly.

Insider Trade Summary

Exercise Price or Tax Liability: 440 shares

Exercise Price or Tax Liability 1 txn

Insider Charbonneau Elissa Joy

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Encompass Health Common Stock	440	$106.15	$47K

Holdings After Transaction: Encompass Health Common Stock — 18,013.061 shares (Direct)

Holdings Before and After: Encompass Health Common Stock, 18,453.061 to 18,013.061 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Encompass Health (EHC) report for Elissa Joy Charbonneau?

Encompass Health reported a tax-withholding disposition of 440 common shares by Chief Medical Officer Elissa Joy Charbonneau. The shares were withheld to satisfy tax obligations triggered by vesting restricted stock, rather than an open market sale.

Was the Encompass Health (EHC) insider transaction an open market sale?

No, the transaction was not an open market sale. The 440 shares were withheld or surrendered to cover tax withholding obligations tied to vesting restricted stock, classified under code F on the Form 4.

How many Encompass Health (EHC) shares were involved in the CMO’s tax withholding?

The filing shows 440 shares of Encompass Health common stock were disposed of to satisfy tax withholding. This disposition reflects shares withheld in connection with restricted stock vesting, rather than a discretionary trade by the executive.

What price per share is reported for the Encompass Health (EHC) tax-withholding transaction?

The Form 4 lists a transaction price of $106.15 per Encompass Health common share. This price is used for reporting the value of the 440 shares withheld to cover the executive’s tax obligations on vested restricted stock.

How many Encompass Health (EHC) shares does the CMO hold after this Form 4 transaction?

After the tax-withholding disposition, Chief Medical Officer Elissa Joy Charbonneau is reported to hold 18,013.061 Encompass Health common shares directly. This figure reflects her remaining ownership following the 440 shares withheld for tax purposes.

What does transaction code F mean in the Encompass Health (EHC) Form 4 filing?

Transaction code F indicates shares were used to pay an exercise price or tax liability. In this case, 440 shares of Encompass Health common stock were withheld or surrendered to satisfy the executive’s tax withholding obligations from vesting restricted stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Charbonneau Elissa Joy

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/23/2026		F		440(1)	D	$106.15	18,013.061	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	/s/ Patrick Darby, attorney-in-fact for Ms. Charbonneau	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.